["[Dialogue between User and Assistant on 2024-01-01 00:00]\n<User>Study these classification examples and pay attention to the categories:\n\nSample: All patients were treated in the intensive care unit , had mechanical ventilation , and were highly catabolic , with a mean daily nitrogen loss of 13.2 + / - 1.8 g. r-hGH was given subcutaneously ( once a day , at 8 PM ) in a dosage of 0.2 IU/kg .\n\nLabels: 2\n\nSample: Lack of training hampers melanoma recognition by physicians .\n\nLabels: 3\n\nSample: Further investigation of this therapeutic approach is warranted as some patients were excluded after randomization .\n\nLabels: 1\n\nSample: Postoperative analgesia was maintained with epidural patient-controlled analgesia using bupivacaine and morphine .\n\nLabels: 2\n\nSample: This incremental cost-benefit translates to savings of $ 547 or $ 835 per patient in group 1 ( compared with patients in group 2 or group 3 , respectively ) during the first year after therapy .\n\nLabels: 4\n\nSample: The study design allowed the knowledge acquired to be evaluated objectively .\n\nLabels: 1\n\nSample: One patient developed a bezoar in the pouch 5 years after gastrectomy .\n\nLabels: 4\n\nSample: One toxic death was observed in each arm due to sepsis in agranulocytosis .\n\nLabels: 4\n\nSample: Primary outcome measures included : Visual Analog Scale for average LBP and the McGill Pain Questionnaire .\n\nLabels: 2\n\nSample: Thirty-six medication-nave children 9-14 years of age , diagnosed with ADHD , were enrolled for 6 weeks in a crossover trial , with 2 weeks of methylphenidate , dextroamphetamine , and a placebo in a randomly assigned , counterbalanced sequence .\n\nLabels: 2\n\nSample: The study was stopped after an interim analysis .\n\nLabels: 4\n\nSample: Cost associated with surfactant replacement treatment per extra survivor in the treatment group and cost per quality adjusted life year for each extra survivor .\n\nLabels: 2\n\nSample: Our results would be compatible with a 1 % or 2 % absolute benefit or harm from oral supplements .\n\nLabels: 1\n\nSample: Part-II trial : 54 of 94 eligible patients were contactable .\n\nLabels: 4\n\nSample: Mean ( SD ) postoperative volume of drained blood was lower in the group receiving tranexamic acid ( 727.50 234 mL ) than in control subjects ( 1208.77 421 mL ) .\n\nLabels: 4\n\nSample: Walking time and number of steps increased significantly under both dual-task conditions compared to walking alone ( p < 0.001 ) without reaching a significant difference between the two dual-task conditions ( respectively , p = 0.131 and p = 0.407 ) , whereas lateral gait instability ( frequency of lateral line stepping-over ) increased significantly in association with counting backward ( p = 0.006 ) but not with the verbal fluency task ( p = 1 ) .\n\nLabels: 4\n\nSample: The aim of this study is to determine if there are significant differences in hemodynamic effects between combined general-regional anesthesia using levobupivacaine 0.25 % 2 ml x kg ( -1 ) via the caudal route in comparison with balanced general anesthesia using continuous infusion of remifentanil in young children undergoing genitourinary surgery .\n\nLabels: 0\n\nSample: Breath hydrogen testing should only be applied in the rare patient with SBS who has an intact ileocecal valve .\n\nLabels: 1\n\nSample: Ninety patients undergoing coronary bypass surgery were randomly divided into six groups according to different blood-conservation methods : group 1 , blood during and after CPB was concentrated by a cell saver ( CS ) ; group 2 , blood was concentrated by means of a hemofiltration device ( HF ) ; group 3 , acute normovolemic hemodilution ( ANH ) was performed in combination with the CS technique ( ANH-CS ) ; group 4 , ANH was carried out in combination with an HF during CPB ( ANH-HF ) ; group 5 , acute plasmapheresis ( APP ) was performed and a CS was used during CPB ( APP-CS ) ; and group 6 , APP was used in combination with an HF device ( APP-HF ) .\n\nLabels: 2\n\nSample: One patient experienced an epileptic seizure at a dose of 60 mg administered twice .\n\nLabels: 4\n\nSample: Amnesia was evident in all midazolam patients but in only a third of propofol patients .\n\nLabels: 4\n\nSample: The sample size calculation was based on the primary outcome and a difference of 15mm on VAS was regarded as clinically relevant , this gave 101 in each group , including a total of 303 women .\n\nLabels: 4\n\nSample: Thirty cavities were restored by Z-100 composite .\n\nLabels: 2\n\nSample: One hundred seventy-five patients , 57.1 % paroxysmal AF , 78.5 % male , underwent AF ablation and esophagoscopy 24 hours thereafter .\n\nLabels: 4\n\nSample: Patients ' pulmonary function measurements improved and asthma symptoms declined when treated with ICS/LABA combination therapy regardless of poly-C repeat genotype .\n\nLabels: 4\n\nSample: In comparison with the pre-treatment , MPT and H/N values were increased obviously ( P < 0.05 ) , and FPQ and APQ decreased clearly in the two groups after the treatment ( P < 0.05 ) , suggesting an improvement of the acoustical parameters after the treatment .\n\nLabels: 4\n\nSample: Sequences were performed at 1.5 T and included scans with high radiofrequency power deposition and/or high gradient dB/dt exposure .\n\nLabels: 2\n\nSample: Effects were assessed by comparing perfusion during the first and last 15 minutes of hip-down loading with a 15-minute baseline .\n\nLabels: 2\n\nSample: In this open-label , multicenter , phase III study , Helicobacter pylori-negative patients aged 50 years or 18-49 years with history of uncomplicated ulcer within the past 5 years , who had osteoarthritis , rheumatoid arthritis , or other condition requiring daily NSAIDs for 12 months received naproxen/esomeprazole twice daily for 12 months .\n\nLabels: 2\n\nSample: No gender-related differences were found .\n\nLabels: 4\n\nSample: A prospective randomized design was used in a study of 245 patients .\n\nLabels: 2\n\nSample: An intent-to-treat analysis showed highly significant decreases in binge/purge behavior with dialectical behavior therapy compared to the waiting-list condition .\n\nLabels: 4\n\nSample: Reduced lipolytic enzyme activities may be one of the major pathophysiological mechanisms contributing to a retarded catabolism of these lipoproteins in patients with renal insufficiency .\n\nLabels: 0\n\nSample: The lower FI was associated with a greater BG AUC ( P < 0.05 ) and smaller AA and ghrelin AUCs ( P < 0.01 ) .\n\nLabels: 4\n\nSample: The primary endpoint was defined as a 20 % improvement from baseline to 6 months in Western Ontario and McMaster Universities ( WOMAC ) OA total score .\n\nLabels: 2\n\nSample: We hypothesized that written information on COPD may help increase awareness of the disease in people at risk of developing it .\n\nLabels: 0\n\nSample: 213 patients ( 110 in the pioglitazone group and 103 in the placebo group ) were available for intention-to-treat analysis .\n\nLabels: 2\n\nSample: We examined the independent and combined associations of physical activity and obesity with incident type 2 diabetes in men and women .\n\nLabels: 3\n\nSample: Patients with hypertension , metabolic syndrome ( MetS ) and diabetes mellitus ( T2DM ) have low body magnesium content ; indeed , magnesium supplementation has been shown to have a positive effect on blood pressure ( BP ) and gluco-metabolic parameters .\n\nLabels: 3\n\nSample: In study 1 , 16 subjects , aged 18-45 years , received maraviroc ( 300 mg b.i.d. ) with and without cotrimoxazole ( 960 mg b.i.d. ; 160 mg trimethoprim and 800 mg sulfamethoxazole ) .\n\nLabels: 2\n\nSample: The study was completed by 32 women on isoflavone and 34 women on placebo .\n\nLabels: 4\n\nSample: Satisfactory effect was obtained in recovery of liver function , improvement of blood lipids , blood viscosity and iconographic parameters , no severe adverse reaction occurred .\n\nLabels: 4\n<Assistant>I've captured all of this valuable information.", "[Dialogue between User and Assistant on 2024-01-02 00:00]\n<User>These labeled training examples are for classification:\n\nSample: The second part focused on a possible improvement of visual performance by comparing a regular grid pattern to a randomly chosen spacing of the laser spots ( n = 16 ) .\n\nLabels: 2\n\nSample: During year 3 , hospitalization for severe dengue , as defined by the independent data monitoring committee criteria , occurred in 18 of 22,177 participants in the vaccine group and 6 of 11,089 participants in the control group .\n\nLabels: 4\n\nSample: Forty-nine patients undergoing elective abdominal prostatectomy were allocated randomly to receive bispectal index ( BIS ) - controlled desflurane/fentanyl ( n = 24 ) or propofol/remifentanil ( n = 25 ) .\n\nLabels: 2\n\nSample: A painful post operative complication was recorded if either a dry socket was present or the patient returned with pain .\n\nLabels: 2\n\nSample: Children and parents completed the child and parent forms , respectively , of a HRQoL questionnaire , the Child Health Questionnaire , on the last day of hospitalization .\n\nLabels: 2\n\nSample: RV ejection fraction was calculated from 3D transthoracic echocardiographic RV volumes , and similarly , fractional area change was computed from RV areas .\n\nLabels: 2\n\nSample: The clinical indications for vascular surgery were an expanding aneurysm ( N = 62 ) or severe claudication ( N = 47 ) .\n\nLabels: 2\n\nSample: Of the 100 subjects enrolled , 90 completed the study .\n\nLabels: 4\n\nSample: TU-100 is an effective treatment option after hepatic resection in patients with liver cancer .\n\nLabels: 1\n\nSample: Outcome measures included smoking cessation rates , treatment retention , and medication side effects .\n\nLabels: 2\n\nSample: Recent studies have reported associations between a variant allele in a let-7 microRNA complementary site ( LCS6 ) within the 3 ` untranslated region ( 3 ` UTR ) of KRAS ( rs61764370 ) and clinical outcome in metastatic colorectal cancer ( mCRC ) patients receiving cetuximab .\n\nLabels: 0\n\nSample: A prospective randomized trial was designed to prove equivalency for two commonly used techniques of surgical skin site preparation .\n\nLabels: 2\n\nSample: Eighty-six patients were entered onto the study ; 85 were assessable for toxicity and 83 for response .\n\nLabels: 4\n\nSample: Significantly more risedronate - than alendronate-treated patients were classified as apparent ` non-responders ' ( i.e. experienced any bone loss ) after 12 months of therapy .\n\nLabels: 1\n\nSample: There was no statistical difference in average platelet levels and platelet recovery rate between mIL-11 and rhIL-11 .\n\nLabels: 4\n\nSample: No significant differences in survival were found between those originally randomized to zidovudine or placebo .\n\nLabels: 4\n\nSample: Hypothyroidism is a prevalent endocrine condition .\n\nLabels: 0\n\nSample: Median OS was 17.8 months ( 95 % CI , 16.0 to 19.5 ) in the ASCENT arm and 20.2 months ( 95 % CI , 18.8 to 23.0 ) in the control arm ( log-rank P = .002 ) .\n\nLabels: 4\n\nSample: QRS duration and morphology are associated with poor prognosis in many different populations , but the predictive value , particularly of the risk of sudden cardiac death ( SCD ) , in asymptomatic patients with AS has not been well studied .\n\nLabels: 0\n\nSample: Thirty-nine patients ( linezolid , 23 ; vancomycin , 16 ) with HAP and 113 patients with bacteremia ( linezolid , 81 ; vancomycin , 32 ) were included in the intent-to-treat group .\n\nLabels: 4\n\nSample: DTaP-IPV / / PRP-T combined vaccine was well tolerated .\n\nLabels: 4\n\nSample: The success rate of placement on the first attempt was high for both devices .\n\nLabels: 4\n\nSample: Pain scores were noted at 0 , 3 , 6 , 12 and 24 h after surgery .\n\nLabels: 2\n\nSample: Of these 11 ( not taking propranolol ) , nine ( 82 percent ) developed postsurgical dissatisfaction syndrome .\n\nLabels: 4\n\nSample: Oral and i.m. dexamethasone levels were compared in a randomized , parallel , crossover bioavailability study involving 11 gravid women in the third trimester of pregnancy .\n\nLabels: 2\n\nSample: Nearly half of the subjects ( 46 % ) had sirolimus Cmax changes which fell outside the bioequivalence window with individual Cmax decreases up to 52 % and increases up to 39 % .\n\nLabels: 4\n\nSample: PD measurements included Combined-Attention and Deportment scores on a rating scale of school behavior ( the Swanson , Kotkin , Agler , M-Flynn , and Pelham ) , global assessments of efficacy , and activity monitor levels during academic seatwork .\n\nLabels: 2\n<Assistant>Noted. I'll remember these details.", "[Dialogue between User and Assistant on 2024-01-03 00:00]\n<User>Here are categorized examples with their respective labels:\n\nSample: One hundred chemotherapy patients were recruited to participate in a randomised , controlled trial in Guangzhou , China .\n\nLabels: 2\n\nSample: All LSVs were sealed by VNUS at duplex follow up .\n\nLabels: 4\n\nSample: This study investigated the influence on steroidogenesis of an interleukin-6 ( IL-6 ) - neutralizing strategy using IL-6 receptor monoclonal antibodies ( referred to as MRA ) .\n\nLabels: 3\n\nSample: The primary end point was dialysis-free survival for 21 days after treatment .\n\nLabels: 2\n\nSample: Motor function ( Fugl-Meyer score ) and activities of daily living ( Barthel 's index ) were assessed .\n\nLabels: 2\n\nSample: After their stones were completely cleared , their biliary strictures failed to dilate satisfactorily .\n\nLabels: 2\n\nSample: The TDT set was compared with the K-soft 5000 in a large , prospective , randomized study .\n\nLabels: 2\n\nSample: This study examined the effect of IE and PC on aided localization performance in the horizontal plane with hearing-impaired listeners .\n\nLabels: 3\n\nSample: The secondary efficacy measures included scores on IIEF question 3 and 4 ( Q3 and Q4 ) , all domain scores of IIEF , and Sexual Encounter Profile Question 2 and 3 ( SEP2 and SEP3 ) along with responses to Global Assessment Question ( GAQ ) and Life Satisfaction Checklist ( LSC ) .\n\nLabels: 2\n\nSample: Parameters such as post-operative pain , swelling and ease of penetration , size of entry and exit wound and injury to adjacent structures were compared .\n\nLabels: 2\n\nSample: Secondary outcomes include postwithdrawal cannabis use , health outcomes , and psychosocial outcomes .\n\nLabels: 2\n\nSample: There was no statistically or clinically significant greater reduction in ADHD symptoms in subjects treated with galantamine HBr relative to those receiving placebo ( P = 0.5 ) .\n\nLabels: 4\n\nSample: The evaluations used pre-intervention and follow-up student surveys that were based on the Transtheoretical Model of the stages of behaviour change .\n\nLabels: 2\n\nSample: One possible mechanism for this action is through an inhibition of P-glycoprotein ( P-gp ) .\n\nLabels: 3\n\nSample: After at least 1 week from the end of the first session , they received the other treatment for 24 hours ( second session ) .\n\nLabels: 2\n\nSample: Optimal hemoglobin targets for chronic kidney disease patients receiving erythropoiesis-stimulating agents remain controversial .\n\nLabels: 3\n\nSample: Originally , patients were randomly allocated to receive either 12 courses of intravenous CMF or eight courses of the same regimen followed by four cycles of ADM. RFS and OS were analyzed by a Cox model taking into account treatment , HER2 status , and the interaction between treatment and HER2 status , adjusting for the effect of other known clinical and biopathologic factors .\n\nLabels: 2\n\nSample: Recent studies have identified an interaction between antiretrovirals used to treat HIV and reduced serum vitamin D levels , but these studies have been done in North American and European populations .\n\nLabels: 0\n\nSample: The level of plasma ET-1 was significantly lower in the trimetazidine group 8 hours and 7 days after reperfusion ( P < 0.05 ) .\n\nLabels: 4\n\nSample: The nursing intervention had both short - and long-term effects on functional , psychological , and emotional variables .\n\nLabels: 1\n\nSample: Serious adverse events occurred in 5 % of patients , except infection , fatigue , and pain .\n\nLabels: 4\n\nSample: Fasting plasma glucose ( FPG ) and the 2-h post-challenge plasma glucose ( 2hPG ) are commonly used to identify those at risk of type 2 diabetes .\n\nLabels: 3\n\nSample: Approximate entropy ( ApEn ) was determined to assess BP irregularity .\n\nLabels: 2\n\nSample: Distance contrast sensitivity and distance visual acuity ( VA ) were measured with the Functional Vision Analyser under photopic ( 85 cd/m ( 2 ) ) and mesopic ( 3.0 cd/m ( 2 ) ) conditions , the latter also under two levels of induced glare : 1.0 lux and 28 lux .\n\nLabels: 2\n\nSample: The incidence of postoperative arrhythmias was also significantly lower in the hANP group as compared with that in the non-hANP group .\n\nLabels: 4\n\nSample: Study 2 ( 105 physician assistant students , one university ) explored the effect of perspective-taking on African American SPs ' satisfaction .\n\nLabels: 2\n\nSample: Evaluations were carried out at baseline and after 30 days of treatment .\n\nLabels: 2\n\nSample: The incidence of nausea was lower in the study group ( 41 % ) than in the control group ( 65 % ) .\n\nLabels: 4\n\nSample: Overall participant responder rates were generally lower in the phase 4 study than those in the phase 3 study with the approved 0.75-mg estradiol dose .\n\nLabels: 4\n\nSample: However , the effect of diuretic use on risk of cardiovascular outcomes did not vary by ADD1 carrier status .\n\nLabels: 1\n\nSample: The positive rate of plasma EMAb was reduced obviously after treatment in Group C with the level lower than that in the other two groups ( P < 0.05 ) .\n\nLabels: 4\n\nSample: A comparison of the PK profile with the oral dosing route of aminophylline was performed after delivery to the small bowel and colon .\n\nLabels: 2\n\nSample: These 2 new prostatitis symptom assessment tools were validated by applying them to 30 similar patients without prostatitis .\n\nLabels: 2\n\nSample: It has been suggested that spironolactone may decrease cardiac fibrosis .\n\nLabels: 0\n\nSample: They received , on two occasions which were separated by at least 2 weeks washout period , 0.375 mg digoxin once daily for 13 days following a loading dose of 0.375 mg given twice on the day before the once daily dosing regimen started .\n\nLabels: 2\n\nSample: The primary analysis included all randomised participants with a baseline weight measurement and a post-baseline weight measurement while on study drug ( last observation carried forward ) .\n\nLabels: 2\n\nSample: At 6 weeks , etoricoxib 5 , 10 , 30 , 60 and 90 mg each demonstrated clinical efficacy superior to placebo .\n\nLabels: 4\n\nSample: Hypoglycemia and the endpoint events during the study were recorded and compared among the study groups .\n\nLabels: 3\n\nSample: In this group of patients during exercise , there was no change in the perception of breathlessness , nor the ventilatory response to carbon dioxide production with change in posture , although peak ventilation was greater in the erect position .\n\nLabels: 1\n\nSample: From 03/2003 to 08/2006 , 1297 consecutive patients underwent isolated bypass surgery in our institution .\n\nLabels: 4\n\nSample: Participants included 210 obese adults ( mean body mass index , 34.0 kg/m ) who were randomized to either a paper diary ( PD ) , personal digital assistant ( PDA ) , or PDA plus daily tailored feedback messages ( PDA + FB ) .\n\nLabels: 2\n\nSample: None used oral contraceptive drugs .\n\nLabels: 2\n\nSample: To investigate homoarginine and asymmetric dimethylarginine ( ADMA ) in controls compared to children with type 1 diabetes ( T1D ) and if homoarginine and ADMA are affected by atorvastatin .\n\nLabels: 3\n<Assistant>Great! I've added this to my knowledge base.", "[Dialogue between User and Assistant on 2024-01-04 00:00]\n<User>I have some labeled classification examples for you to study:\n\nSample: Correlation of percent TBSA closed with CSS at POD 28 with percent TBSA full-thickness burn generated an r value of 0.37 ( p < 0.0001 ) .\n\nLabels: 4\n\nSample: Grade 3-4 heart failure occurred in 26 ( 3 % ) patients in the TAC group and 17 ( 2 % ) patients in the FAC group , and caused death in two patients in the TAC group and four patients in the FAC group .\n\nLabels: 4\n\nSample: Twelve patients completed the bioavailability and pharmacokinetic studies .\n\nLabels: 4\n\nSample: Signs of recurrence of blockade were not observed .\n\nLabels: 4\n\nSample: A total of 80 patients entered the study .\n\nLabels: 2\n\nSample: Levalbuterol appears to provide a better therapeutic index than the standard dose of racemic albuterol .\n\nLabels: 1\n\nSample: The treatment included four sessions of manipulation and stabilizing exercises aiming to correct the lumbopelvic rhythm .\n\nLabels: 2\n\nSample: In patients who received milrinone , flow increased by 24 % to 50 + / -17 mL/min , p < 0.05 ; whereas with epinephrine , it remained essentially unchanged ( 33 + / -10 v. 31 + / -11 mL/min ) .\n\nLabels: 4\n\nSample: An intent-to-treat analysis ( n = 123 ) revealed there were no significant Group x Time differences ( p = .15 ) in weight loss at either 6 ( -6.8 + / - 7.8 vs. -5.1 + / - 4.8 , p = .15 ) or 12 months ( -5.1 + / - 7.1 kg vs. -3.5 + / - 5.1 kg , p = .17 , for Internet-only and I+IPS , respectively ) .\n\nLabels: 4\n\nSample: Excellent agreement was reported between acid output ( 95 % limits of agreement , -1.27 to 1.61 mEq/h ) and acid concentration ( 95 % limits of agreement , -0.01 to 0.01 mEq/mL ) , although poor agreement was observed between volume output measured .\n\nLabels: 4\n\nSample: The objectives of this study were to determine whether support from a contraceptive personal assistant could increase the uptake of LARCs by 3 months postpartum , and to identify risk factors for nonuptake of LARCs among women who planned LARC use .\n\nLabels: 0\n\nSample: During the anesthesia induction , the QTc interval was significantly shorter when esmolol was co-administered with either propofol or metohexital .\n\nLabels: 1\n\nSample: To determine if fixed-dose , weight-adjusted , subcutaneous unfractionated heparin is as effective and safe as low-molecular-weight heparin for treatment of venous thromboembolism .\n\nLabels: 3\n\nSample: Smoking enhances clopidogrel-induced platelet inhibition , which may explain the higher relative benefit among smokers observed in trials evaluating dual antiplatelet therapy .\n\nLabels: 0\n\nSample: Remission rates were 19.0 % ( antibiotics ) vs. 15.8 % ( placebo ) at 3 months ( P = 0.59 ) .\n\nLabels: 4\n\nSample: Partial response was observed in 8 of 20 NP-treated patients ( 40.0 % ) and in 12 of 28 NI-treated patients ( 42.8 % ) .\n\nLabels: 4\n\nSample: The investigation was a retrospective cohort study of cardiac arrest patients treated by layperson CPR and one model of automated external defibrillator ( AED ) as part of the Public Access Defibrillation Trial ( n = 26 ) .\n\nLabels: 2\n\nSample: Ingestion of a meal rich in fat previously used for deep frying in a commercial fast food restaurant resulted in impaired arterial endothelial function .\n\nLabels: 1\n\nSample: To evaluate the effect of dual blockage of the renin-angiotensin system by adding maximal recommended dose of ARB with maximal recommended dose of ACE inhibitors in type 2 diabetic patients with diabetic nephropathy .\n\nLabels: 3\n\nSample: The amount that participants were willing to pay was comparable to that reported for the treatment of other chronic medical disorders and higher than the actual cost of depression treatment .\n\nLabels: 1\n\nSample: Some adverse events occurred and there were no significant differences among groups .\n\nLabels: 4\n\nSample: NCT00473876 .\n\nLabels: 0\n\nSample: The small number of patients and the design of the study did not permit conclusions to be drawn about the efficacy of the treatment .\n\nLabels: 1\n\nSample: Adverse events led to discontinuation of 20 % of patients from pregabalin and 7 % from placebo .\n\nLabels: 4\n\nSample: Prescription of frequent courses of oral prednisolone was the most common reason for withdrawing as specified in the protocol ( 69 patients in the FP group withdrew due to respiratory symptoms , compared with 93 patients in the placebo group ) .\n\nLabels: 4\n\nSample: These results suggest that intraoperative MMC application , during combined phacoemulsification and trabeculectomy surgery , does improve early filtration as shown by overall lower IOPs and less antiglaucoma medication use .\n\nLabels: 1\n\nSample: Participants were randomly allocated to either 23-valent pneumococcal polysaccharide vaccine ( n = 502 ) or placebo ( n = 504 ) .\n\nLabels: 2\n\nSample: The exclusion criteria included a Mallampati score = or < 2 and a Patil distance > 6 cm .\n\nLabels: 2\n\nSample: The most patients ranked as excellent for the first CobraPLA insertion ( Grade 1 ) were found in Group R4 , which was significantly higher than Groups R1 and R2 ( P < 0.01 ) , whereas no significant difference was found when compared with Group R3 .\n\nLabels: 4\n<Assistant>Thanks for sharing. I've committed this to memory.", "[Dialogue between User and Assistant on 2024-01-05 00:00]\n<User>These are labeled examples for classification tasks:\n\nSample: Exercise time was not different in the two groups .\n\nLabels: 4\n\nSample: After follow-up , the CG was offered the computerized training and assessed after this ( A4 ; n = 8 ) .\n\nLabels: 2\n\nSample: KT3-671 reduced office systolic BP at all doses and diastolic BP at some of the doses .\n\nLabels: 1\n\nSample: Three eyes ( 15 % ) in the treatment group developed an intraocular pressure rise that was managed by topical medication .\n\nLabels: 4\n\nSample: After 16 weeks , the TEF was not reduced in either dietary group .\n\nLabels: 4\n\nSample: 424 patients entered the study .\n\nLabels: 4\n\nSample: A 2-group experimental design was used to compare cooling via convection ( n = 20 ) with cooling via conduction ( n = 17 ) in critically ill adults with an infection-related fever of 38.5 degrees C or greater .\n\nLabels: 2\n\nSample: Case conferences were judged to be useful regardless of their timing .\n\nLabels: 4\n\nSample: Simulations demonstrated accumulation in breast milk after multiple doses .\n\nLabels: 4\n\nSample: This preliminary study emphasizes the need to have more than subjective clinical scales for determination of sequence of treatments .\n\nLabels: 1\n\nSample: For this reason , the value of the sentinel node biopsy ( SNB ) procedure for this indication is debated .\n\nLabels: 0\n\nSample: Non - inferiority was demonstrated for the low group ( p = 0.0022 ) with a difference from baseline to 6 months of 0.24 in the low and of 0.16 in the high group .\n\nLabels: 4\n\nSample: Alcohol or drug use should be assessed prior to adolescent MDD treatment and monitored even after MDD recovery .\n\nLabels: 1\n\nSample: The ability of sitostanol to reduce cholesterol absorption was measured directly by including hexadeuterated cholesterol tracer in a standard test breakfast and measuring plasma tracer concentration 4 and 5 d later by gas chromatography-negative ion mass spectrometry .\n\nLabels: 2\n\nSample: Group A was treated with betamethasone injection and group B with NSAIDs , both with concomitant use of wrist splints .\n\nLabels: 2\n\nSample: Anatomic location of the tube was verified by thoracotomy of the left side of the chest .\n\nLabels: 2\n\nSample: Group B including 64 cases : instillation of 50-60 mg BCG plus 100 mg PAMBA ; Group C including 65 cases : 100-120 mg BCG plus 2.0 g epsilon-aminocaproic acid ( EACA ) ; Group D including 64 cases : 50-60 mg BCG plus 2.0 g EACA ; Group E ( control group ) including 67 cases : 100-120 mg BCG .\n\nLabels: 2\n\nSample: Assisted zona hatching was performed on day-3 embryos from the control-group patients .\n\nLabels: 2\n\nSample: A two-compartment open model was fitted on the individual observed data .\n\nLabels: 2\n\nSample: The standard surgery for early-stage endometrial cancer is total abdominal hysterectomy ( TAH ) and bilateral salpingo-oophorectomy , which is associated with substantial morbidity .\n\nLabels: 0\n\nSample: Fifty-two patients completed the study .\n\nLabels: 4\n\nSample: Patients of the control group were treated by oral administration of Celebrex ( a specific inhibitor of COX-2 , 200 mg/time , once daily , 4 weeks together ) .\n\nLabels: 2\n\nSample: More patients treated with XP13512 ( 76.1 % ) were responders compared with placebo ( 38.9 % ; adjusted OR 5.1 ; 95 % CI , 2.8 to 9.2 ; p < 0.0001 ) .\n\nLabels: 4\n\nSample: These findings also suggest that , taken long-term , BZDs do not aid sleep .\n\nLabels: 1\n\nSample: The identity of injected compound was blinded to the patient and to the physician .\n\nLabels: 2\n\nSample: Therefore we evaluated the diagnostic value of tcPo ( 2 ) and TP in management of clinically suspected critical leg ischemia .\n\nLabels: 3\n\nSample: Systolic arterial pressure and heart rate decreased significantly in patients given 75 and 150 micrograms clonidine .\n\nLabels: 4\n\nSample: Participants in the control group received group counselling from the PCU staff as usual , while those participants in the experimental group received one-on-one advice from a community pharmacist along with the weight loss handbook for self-study .\n\nLabels: 2\n\nSample: Twenty-nine patients continued in SL0006 , with interim analysis at a median exposure of 120 ( range 13-184 ) weeks .\n\nLabels: 2\n\nSample: SGN-15 is an antibody-drug conjugate ( ADC ) , consisting of a chimeric murine monoclonal antibody recognizing the Lewis Y ( Le ( y ) ) antigen , conjugated to doxorubicin .\n\nLabels: 3\n\nSample: The primary outcome was a composite of death , gross motor disability , cognitive or language delay , severe hearing loss , or bilateral blindness at a corrected age of 18 months .\n\nLabels: 2\n\nSample: Although the third-generation aromatase inhibitors are generally well tolerated , side-effects still occur in up to 40 % of women .\n\nLabels: 3\n\nSample: There were no significant differences between treatment groups .\n\nLabels: 4\n\nSample: The evaluation of the SF12 sum scores showed a significant gain in quality of life within the bifidobacteria group .\n\nLabels: 4\n\nSample: Fifty-two hospitalized infants ( mean + / - SD age , 2.9 + / - 2.1 months ) with viral bronchiolitis received either inhalation of epinephrine , 1.5 mg , in 4 mL of 0.9 % saline solution ( group 1 ; n = 25 ) or inhalation of epinephrine , 1.5 mg , in 4 mL of 3 % saline solution ( group 2 ; n = 27 ) .\n\nLabels: 2\n\nSample: To assess the effect of plasmafiltration ( PF ) on biochemical markers of inflammation , cytokines , organ dysfunction , and 14-day mortality in human sepsis .\n\nLabels: 3\n\nSample: According to the hypothesis that overweight patients have higher levels of aromatase enzyme availability , we investigated the influence of body mass index ( BMI ) on the efficacy of adjuvant endocrine therapy in premenopausal patients in a retrospective analysis of the Austrian Breast and Colorectal Cancer Study Group ( ABCSG ) 12 trial .\n\nLabels: 3\n\nSample: In each patient , 1 mandibular incisor was randomly selected for analysis .\n\nLabels: 2\n\nSample: All subjects also received brief coping skills therapy .\n\nLabels: 2\n\nSample: Most participants completed three or more visits ( 69.6 % ) , with 205 ( 56.2 % ) completing all four .\n\nLabels: 4\n\nSample: The 2 - and 5-year survival rates for Group A patients were 81.8 % and 18.5 % .\n\nLabels: 4\n\nSample: Surgical success was defined as patient satisfaction , disappearance of epiphora and lacrimal patency up to 12 months after surgery .\n\nLabels: 2\n\nSample: FOLFIRI patients received irinotecan 180 mg/m ( 2 ) on days 1 , 15 , 29 ; on days 1 , 2 , 15 , 16 , 29 , 30 , patients received leucovorin 200 mg/m ( 2 ) , bolus 5-fluorouracil 400 mg/m ( 2 ) , and 5-fluorouracil 600 mg/m ( 2 ) as 22-hour infusion .\n\nLabels: 2\n\nSample: The aim of this study was to see how these subscales may change over the course of a 12-week study .\n\nLabels: 3\n\nSample: Healing was clinically assessed at 1 week and 1 month post-surgically .\n\nLabels: 2\n<Assistant>I've successfully recorded all of this data.", "[Dialogue between User and Assistant on 2024-01-06 00:00]\n<User>Please memorize these classification examples and their labels:\n\nSample: When analysing the ROC curve of NT-proBNP in baseline and atrial fibrillation at day 30 the result was 0.57 .\n\nLabels: 4\n\nSample: The parent compound ciclesonide was not detected in any of the serum samples after oral administration ; serum concentrations of des-CIC were mostly near or below the lower limit of quantification .\n\nLabels: 4\n\nSample: Body mass index , blood pressure and urinary catecholamines were unchanged by CPAP therapy , but 8-isoprostane concentrations decreased ( 38.5 ( 24.2-58 .7 ) pg/ml at baseline vs 22.5 ( 16.2-35 .3 ) pg/ml on CPAP , p = 0.0001 ) and NOx levels increased ( 280 ( 177-707 ) vs 1373 ( 981-1517 ) micromol/l , p = 0.0001 ) after CPAP .\n\nLabels: 4\n\nSample: Suppression of Ang II and reduction in blood pressure were temporally dissociated , both with the ACE inhibitor and the renin inhibitor .\n\nLabels: 1\n\nSample: Conventional total knee arthroplasty is performed with use of an intramedullary alignment guide , which produces elevated intramedullary pressure that can create fat emboli .\n\nLabels: 0\n\nSample: No significant effect of clenbuterol or exercise on response variables was found between treatment and control groups at any time point or within groups over time .\n\nLabels: 4\n\nSample: A total of 48 patients in group 1 ( 98 % ) and 49 in group 2 ( 100 % ) reported no discomfort or only mild discomfort .\n\nLabels: 4\n\nSample: A letter from the local cervical screening programme commissioner resulted in a small , non-significant increase in uptake .\n\nLabels: 1\n\nSample: Internal hemodiafiltration may substitute low-flux bicarbonate dialysis , but we need new prospective studies about long-term hard end-points .\n\nLabels: 1\n\nSample: The main outcome measures were the excretion of Ca and P by weekly spot urine measurements , the degree of dolichocephalic deformation ( fronto-occipital diameter to biparietal diameter ratio , FOD/BPD ) at 36 weeks postmenstrual age , and the BMC ( by dual-energy x-ray absorptiometry ) at discharge .\n\nLabels: 2\n\nSample: Fast RNFL scan and a fast macular scan with OCT were performed in both groups .\n\nLabels: 2\n\nSample: Patients received placebo or NAC capsules for once-daily dosing on the intervening days .\n\nLabels: 2\n\nSample: We observed that the recovery times were similar in the four groups .\n\nLabels: 4\n\nSample: With regard to maintaining remission , UC patients in group A ( 63.6 % ) presented significantly higher rates ( P < 0.0015 and P < 0.001 , respectively ) versus 14.3 % in group B and none in group C. For CD patients , statistical differences ( P < 0.001 ) existed when comparing rates in groups A ( 53.3 % ) and B ( 66.6 % ) versus none in group C. Noticeable side effects appeared in 13.3 % of patients from group A and 11.5 % from group B.\n\nLabels: 4\n\nSample: The aim of the study was to evaluate the uricosuric effect of the angiotensin II receptor antagonist , losartan , in hypertensive patients with renal transplants who are treated with cyclosporin A ( CsA ) .\n\nLabels: 0\n\nSample: This is especially relevant in research settings .\n\nLabels: 1\n\nSample: This study demonstrated the efficacy of naftidrofuryl versus placebo in patients with intermittent claudication with a highly significant and clinically relevant difference and confirmed its good safety profile .\n\nLabels: 1\n\nSample: Scanography is a valuable method for examination of mandibular third molars before removal and the PSP digital receptors in this study were equal to film for this purpose .\n\nLabels: 1\n\nSample: Both end-points were achieved by a significantly higher proportion of subjects in the varenicline group than in the placebo group .\n\nLabels: 4\n\nSample: Patients with type 2 DM and a glycosylated hemoglobin ( HbA ( 1c ) ) value > or = 7.5 % who were using insulin ( with or without OAMs ) entered a 3-month insulin intensification phase to achieve blood glucose targets with insulin monotherapy .\n\nLabels: 2\n\nSample: Our findings may have implications for future trial design in subcortical vascular cognitive impairment .\n\nLabels: 1\n\nSample: This analysis supports the current definitions of ischaemic events but suggests that more liberal definitions of bleeding events may also be relevant to late mortality .\n\nLabels: 1\n\nSample: This purpose of this study was to determine whether participation in the Work-Ordered Day program of the Clubhouse model has a positive effect on vocational outcomes .\n\nLabels: 3\n\nSample: we recruited 362 patients , of whom 181 were randomized to each group .\n\nLabels: 4\n\nSample: Pretherapy sputum culture and sensitivity ( c/s ) were tested and patients were randomized and supplied with either tablet Cefaclor 375 mg or tablet Clarithromycin 250 mg to be taken twice daily .\n\nLabels: 2\n\nSample: Sixty-one participants ( 84.7 % ) completed follow-up at Month 3 .\n\nLabels: 4\n\nSample: A total of 110 overweight/obese ( body mass index = 25-40 ) ( mean [ SD ] age = 44.3 [ 8.6 ] years ; body mass index = 30.5 [ 3.6 ] ) male employees at Tomago Aluminium ( New South Wales , Australia ) were randomized to either ( i ) Workplace POWER program ( n = 65 ) or ( ii ) a 14-week wait-list control group ( n = 45 ) .\n\nLabels: 2\n\nSample: The programme was followed up by a consulting diabetologist .\n\nLabels: 2\n\nSample: The effect of statin therapy on Lp-PLA ( 2 ) mass and activity in children with familial hypercholesterolemia ( FH ) is also not known .\n\nLabels: 0\n\nSample: Substantial and sustained dietary fat reduction with associated weight change can be achieved at relatively low cost within the context of conventional multimodality clinical management of postmenopausal women with localized breast cancer .\n\nLabels: 1\n\nSample: We studied the feasibility and safety of hypothermia and thrombolysis after acute ischemic stroke .\n\nLabels: 3\n\nSample: No significant differences in the changes in maternal or fetal hemodynamic parameters from baseline to estimated time of peak nicotine exposure were observed between those who smoked cigarettes and those who chewed nicotine gum .\n\nLabels: 4\n\nSample: Ten active female subjects participated ( 32 + / - 7 yrs ( mean + / - SD ) ; 65.7 + / - 16.4 kg ; VO2peak 40.0 + / - 7.5 ml.kg-1 .\n\nLabels: 2\n\nSample: Swan-neck catheters were associated with a slightly better ESI rate , but SNC catheters are not routinely recommended because of a high migration rate .\n\nLabels: 1\n\nSample: To detect the mechanical effect of a viscoelastic heel orthosis .\n\nLabels: 3\n\nSample: The 2 groups had similar HD symptoms at baseline , but overall , patients in the placebo group had numerically higher grades of HD than did patients in the iferanserin group .\n\nLabels: 4\n\nSample: Seventy-three subjects completed the study .\n\nLabels: 2\n\nSample: In contrast there was no improvement in the UC arm .\n\nLabels: 4\n\nSample: In the aprepitant group , 66 % of women had overall complete response compared with 69 % of men .\n\nLabels: 4\n\nSample: For uteri with an intermediate volume , bimanual examination and ultrasound are less reliable .\n\nLabels: 1\n\nSample: Patients were randomly assigned to receive 1 tablet of tramadol/acetaminophen 37.5 / 325 mg QD and 1 placebo BID for 3 days , followed by 1 active tablet BID and 1 placebo QD for 4 days , followed by 1 active tablet TID for 7 days ( titration group ) or 1 tablet of combined tramadol 37.5 mg/acetaminophen 325 mg TID for 14 days ( nontitration group ) .\n\nLabels: 2\n\nSample: From a baseline pain rating of 3.2 ( SD 2.3 ) in the neck among neck cases , 1WS experienced a reduction of 1.14 ( 95 % CI 0.17 to 2.10 ) , 3WS 1.88 ( 0.90 to 2.87 ) and 9WS 1.35 ( 0.24 to 2.46 ) which is considered clinically significant .\n\nLabels: 4\n<Assistant>Wonderful. I'll remember these key points.", "[Dialogue between User and Assistant on 2024-01-07 00:00]\n<User>These labeled training examples are for classification:\n\nSample: Adverse effects were also studied .\n\nLabels: 2\n\nSample: For health status , the only difference found was that at the time of referral , patients who had been referred in-house and judged to need hospital referral reported themselves as being less able on the ` Physical function ' subscale of the SF-36 than patients who were referred in-house and judged to not need hospital referral .\n\nLabels: 4\n\nSample: Owing to its dual regulation on blood flow of VA and BA , the therapeutic effect of acupuncture plus Ligustrazine was better than that of simple Ligustrazine .\n\nLabels: 1\n\nSample: There was a strong correlation between freedom from graft rejection during the first month after transplantation and ( a ) AUC0-6 and ( b ) Cmax at days 5 and 10 after transplantation , but only in the NEO group did this reach statistical significance .\n\nLabels: 4\n\nSample: Propofol at 1 mg/kg and thiopentone at 5 mg/kg used for modified ECT in this study resulted in significant increases in heart rates .\n\nLabels: 1\n\nSample: The final endoscopic investigation 6 weeks yielded healing rates of 90 % ( group 1 ) or 96 % ( group 2 ) .\n\nLabels: 4\n\nSample: Topical antifungal treatments are recommended but rarely used as first-line therapy for oropharyngeal candidiasis ( OPC ) in patients with cancer .\n\nLabels: 0\n\nSample: Procedure time was statistically significantly shorter with the NovaSure system ( p < 0.0001 ) .\n\nLabels: 4\n\nSample: Unequivocal evidence of injury specific to reperfusion was not observed in this study suggesting that much of the damage observed during reperfusion may be a continuation of injury induced during the ischemic period and not specific to reperfusion per se .\n\nLabels: 1\n\nSample: This study aimed at comparing total i.v. anaesthesia ( TIVA ) with monitored anaesthesia care ( MAC ) during day-surgery operative hysteroscopy regarding : operation time , time to mobilization and discharge , and patient satisfaction .\n\nLabels: 0\n\nSample: For each OAR , AS DSC was statistically different from both AS+R and MS ROIs ( all Steel-Dwass p < 0.01 ) except the spinal cord and the mandible , suggesting oversight of AS/MS processes is required ; AS+R and MS DSCs were non-different .\n\nLabels: 4\n\nSample: Tubeless PCNL in selected patients is a secure , effective , and less morbid procedure that does not compromise patient safety and concerns .\n\nLabels: 1\n\nSample: Clinical data and utilization of key health resources ( medication only ) were assessed within an 8-week clinical trial conducted in Brazil .\n\nLabels: 2\n\nSample: Parameters were evaluated at baseline and monthly .\n\nLabels: 2\n\nSample: Ultrasound-guided blocks took longer on average to perform than traditional blocks ( 159 vs 79 secs ; P < 0.001 ) .\n\nLabels: 4\n\nSample: At week 12 , the mean change in intraocular pressure for dorzolamide was statistically significant from baseline ( -7.3 mm Hg [ -20.6 % ] and -7.1 mm Hg [ -23.3 % ] ) in the younger and older cohorts , respectively ; P < .001 for both .\n\nLabels: 4\n\nSample: The objective of this study was to determine the extent of poor symptom recognition in this group of women .\n\nLabels: 3\n\nSample: No decline occurred in patients with Fio ( 2 ) levels of 0.25 and 0.30 .\n\nLabels: 4\n\nSample: The groups were similar at baseline , with one exception : the saline solution group had a higher estimated blood volume at baseline than the tranexamic acid group .\n\nLabels: 4\n\nSample: Women randomised to screening were offered three annual screens that involved measurement of serum CA 125 , pelvic ultrasonography if CA 125 was 30 U/mL or more , and referral for gynaecological opinion if ovarian volume was 8.8 mL or more on ultrasonography .\n\nLabels: 2\n\nSample: Insulin lispro Mix75/25 ( Mix75/25 ) is the first available insulin formulation in which both the rapid-acting and basal components are insulin analogues .\n\nLabels: 0\n\nSample: We devised a randomized , double-blinded , controlled crossover trial to treat patients with chronic upper body pain syndromes .\n\nLabels: 2\n\nSample: After one year , the pharmacist-only group will be intensified by the addition of HP support and maintenance will be assessed by phasing out HP support from the pharmacist plus HP group ( crossover design ) .\n\nLabels: 2\n\nSample: The EORTC QLQ-C30 and QLQ-LC13 were assessed before treatment and 2 weeks , 6 weeks , 3 , 6 and 12 months after treatment .\n\nLabels: 2\n\nSample: Ten adverse events were reported during the study ; 7 subjects complained of pain during blood sampling , and 3 had a blocked venous catheter .\n\nLabels: 4\n\nSample: Oral , but not transdermal treatment , significantly reduced arginine compared with placebo .\n\nLabels: 4\n\nSample: Patients were examined for 3 months to determine similar outcomes for standard indices of safety , predictability , efficacy , and enhancement rates .\n\nLabels: 2\n\nSample: In the C. fuscescens group , all 12 arms pretreated with conventional sunscreen demonstrated erythema , and all subjects noted subjective discomfort .\n\nLabels: 4\n\nSample: So given the advantages of its stability at room temperature , low cost and easy route of administration , misoprostol appears to be a better choice , and a low dose is enough .\n\nLabels: 1\n\nSample: To investigate the effect of supplementation on the cognitive function of older people with cobalamin deficiency by a randomized trial .\n\nLabels: 3\n\nSample: University teaching hospital , La Sapienza , Italy .\n\nLabels: 2\n\nSample: Bactericidal/permeability-increasing protein ( BPI ) is found in azurophilic granules of human neutrophils , which is bactericidal and neutralizes lipo-polysaccharide ( LPS ) .\n\nLabels: 0\n\nSample: There is evidence that household point-of-use ( POU ) water treatment products can reduce the enormous burden of water-borne illness .\n\nLabels: 0\n\nSample: Respiratory complications account for almost half of the readmissions to the critical care unit .\n\nLabels: 0\n\nSample: The sample size is designed to detect a statistically significant decrease in reported pain , determined by a two tailed test and a p value of 0.05 .\n\nLabels: 2\n\nSample: We tested this hypothesis by evaluating disease-free survival ( DFS ) for 1033 premenopausal patients who received definitive surgery either during the follicular phase ( n = 358 ) or the luteal phase ( n = 675 ) .\n\nLabels: 2\n\nSample: The Chinese Lam Assessment of Stages of Employment Readiness ( C-LASER ) , the Chinese State Trait and Anxiety Inventory ( C-STAI ) , and the SF-36 were the outcome measures for the two groups before and after the training program to observe the changes in subjects ' work readiness status , emotional status and their health related quality of life pre - and post-training program .\n\nLabels: 2\n\nSample: Compared to a stable BMI ( + / -0.5 kg/m ( 2 ) ) , a 0.5-2 .0 kg/m ( 2 ) increase had a multivariable-adjusted RR of 1.00 ( 0.86-1 .16 ) .\n\nLabels: 4\n\nSample: The 1.25 mg dose increased only urate concentrations , whereas the 10 mg dose affected all the above biochemical variables .\n\nLabels: 4\n\nSample: Sixteen patients had cataract at the first visit ( seven in the tamoxifen group and nine in the toremifene group ) .\n\nLabels: 4\n<Assistant>I've processed this information and will remember it.", "[Dialogue between User and Assistant on 2024-01-08 00:00]\n<User>Here are some examples with classification labels to remember:\n\nSample: From March 1992 to January 2003 , when the study was prematurely closed because of poor accrual , 541 patients with small ( 5 cm ) , solitary , T1-T2 N0 M0 ( Union Internationale Contre le Cancer [ UICC ] 1978 ) tumours suspicious for renal cell carcinoma ( RCC ) and a normal contralateral kidney were randomised to NSS or RN in European Organisation for Research and Treatment of Cancer Genito-Urinary Group ( EORTC-GU ) noninferiority phase 3 trial 30904 .\n\nLabels: 2\n\nSample: In this randomized study , 380 patients were randomly allocated to receive either combined 400 g sublingual misoprostol before surgery plus 20 IU oxytocin after delivery of baby ( n = 190 ) or intravenous 100 g carbetocin ( n = 190 ) .\n\nLabels: 2\n\nSample: The 62 couples were randomly equally divided into two groups .\n\nLabels: 2\n\nSample: Multicentre , single blind randomised trial .\n\nLabels: 2\n\nSample: A combination of both treatments could potentially benefit many women with vulvar vestibulitis .\n\nLabels: 1\n\nSample: Laparoscopic-naive students can easily acquire laparoscopic camera navigation ( LCN ) skills , yet it is unclear whether this translates into improved LCN performance in the operating room and whether students retain these skills over time .\n\nLabels: 0\n\nSample: This technique appeared to be inadequate to produce BIS values less than 60 in isoflurane and sevoflurane .\n\nLabels: 0\n\nSample: There are conflicting data on the clinical benefit from early administration of abciximab from a large randomized trial and a registry .\n\nLabels: 0\n\nSample: Twenty-four healthy young men were treated with a 7-day course of oral DHEA ( 150 mg b.d. ) or placebo in a double blind , random , crossover and balanced order design .\n\nLabels: 2\n\nSample: RAP followed by PIR did significantly reduce depressive symptoms relative to those students not receiving PIR .\n\nLabels: 4\n\nSample: Following a short recruitment period , the recruitment target was achieved at the large , but not smaller , club .\n\nLabels: 4\n\nSample: The results of this study may lead to an improved understanding of the genetic determinants of lipids response to treatment .\n\nLabels: 1\n\nSample: The relative changes of plasma concentrations of glucoses and cortisol were higher at 1 h after operation and immediately after extubation in group C when compared with group R.\n\nLabels: 4\n\nSample: The primary outcome measure was a 50 % decrease in knee pain from baseline to week 24 .\n\nLabels: 2\n\nSample: Area under the plasma ZDV concentration-time curve ( AUC ) was not statistically different across the study treatments .\n\nLabels: 4\n\nSample: In the no closure subgroup of 91 women with subcutaneous fat thickness more than 2 cm , the incidence of wound disruption was significantly higher than that of the 68 women with subcutaneous tissue thickness at least 2 cm .\n\nLabels: 4\n\nSample: Prospective , single-blind , randomized , controlled intervention trial .\n\nLabels: 2\n\nSample: Two parallel groups received either DMM nasal spray or placebo for 2 weeks .\n\nLabels: 2\n\nSample: We sought to determine the effects of continuous positive airway pressure ( CPAP ) on mitral regurgitant fraction ( MRF ) and plasma atrial natriuretic peptide ( ANP ) concentration in patients with congestive heart failure ( CHF ) .\n\nLabels: 3\n\nSample: Amitriptyline orally , at doses of 10 , 25 and 50 mg at night-time and pregabalin orally , at doses of 75 , 150 and 300 mg twice daily , by optional titration was used .\n\nLabels: 2\n\nSample: For most serum markers , collection of 2 or more measurements per person is desirable to increase the ability to detect associations between biomarkers and health-related variables .\n\nLabels: 1\n\nSample: Since quinine is not without the potential for side effects and drug interactions , clinicians need to carefully consider the likelihood of modest benefit associated with quinine against the potential for side effects and drug-drug interactions .\n\nLabels: 1\n\nSample: Human immunodeficiency virus ( HIV ) infection , malaria , and diarrheal disease adversely affect growth and are associated with increased prevalence of vitamin A deficiency .\n\nLabels: 3\n\nSample: This case report shows that ketamine-induced NMDA receptor blockade significantly relieved glossopharyngeal neuralgia in this patient .\n\nLabels: 1\n\nSample: Repetitive transcranial magnetic stimulation ( rTMS ) has been proposed as a new treatment option for depression .\n\nLabels: 0\n\nSample: A population pharmacokinetic analysis was performed on samples from patients with deep vein thrombosis participating in a randomized dose-finding study ( THRombin Inhibitor in Venous thrombo-Embolism [ THRIVE I ] ) .\n\nLabels: 2\n\nSample: These differential effects on CBP and LVMI may have important implications for cardiovascular risk reduction .\n\nLabels: 1\n\nSample: This is the first evidence that local hyaluronan injections modify the structural organization of the human knee synovium in OA .\n\nLabels: 1\n\nSample: Angiographic variables showed no statistically significant difference .\n\nLabels: 4\n\nSample: These patients were followed up for a mean ( SD ) of 3.3 ( 1.2 ) years .\n\nLabels: 2\n\nSample: Granisetron ( 10 micrograms/kg ) was administered as a 30-second intravenous bolus infusion within 5 minutes before the start of chemotherapy , and ondansetron ( 32 mg ) was administered as a 15-minute intravenous infusion beginning 30 minutes before the start of chemotherapy .\n\nLabels: 2\n\nSample: The changes in nutritional parameters were also comparable with both formulas .\n\nLabels: 4\n\nSample: Of the 450 HIV-1-seropositive men and women who underwent screening , 262 initiated treatment and 174 completed the 9-month follow-up assessment .\n\nLabels: 4\n\nSample: A low carvedilol dose is effective if the HR and/or plasma BNP has been reduced .\n\nLabels: 1\n\nSample: Evidence for efficacy of disease-modifying drugs in multiple sclerosis ( MS ) comes from trials of short duration .\n\nLabels: 0\n\nSample: 132 patients had a pulmonary exacerbation and were randomised during the 4.5-year study period .\n\nLabels: 4\n\nSample: Albuterol appears to reduce the likelihood that patients with acute bronchitis will be coughing after 7 days following initiation of treatment .\n\nLabels: 1\n\nSample: Matrix metalloproteinase ( MMP ) -8 accounted for approximately 80 % of total collagenase in GCF , with much less MMP-1 and -13 , and SDD reduced the odds of elevated MMP-8 by 60 % compared to placebo ( P = 0.006 ) .\n\nLabels: 4\n\nSample: Systolic blood pressure decreased in all but the patients receiving 1.0 MAC desflurane .\n\nLabels: 4\n\nSample: Chemotherapy consisted of four week cycles of intravenous leucovorin ( 200 mg/m2/day ) followed by 5-fluorouracil ( 550 mg/m2/day ) and cisplatin ( 20 mg/m2/day ) , each drug being given on the first four days of the cycle .\n\nLabels: 2\n<Assistant>I've processed this information and will remember it.", "[Dialogue between User and Assistant on 2024-01-09 00:00]\n<User>Here are some classification examples to learn from. Please pay attention to the labels:\n\nSample: Seventy percent of subjects indicated they would `` always '' request buffered lidocaine for peripheral IV insertion .\n\nLabels: 4\n\nSample: The mastectomy flap fixation technique is a valuable procedure that significantly decreases the incidence of seroma formation , and reduces the duration and amount of drained fluid .\n\nLabels: 1\n\nSample: A total of 107 febrile neutropenic cancer patients were randomly assigned to empiric therapy with ticarcillin-clavulanate ( 4 g ticarcillin + 0.1 g clavulanate i.v. every 4 hours ) plus netilmicin ( 2 mg/kg i.v. every 8 hours ) with or without rh-GMCSF ( 3 micrograms/kg per day i.v. ) .\n\nLabels: 2\n\nSample: All patients had a conventional 2-side trabeculectomy and phacoemulsification with foldable posterior chamber intraocular lens implantation .\n\nLabels: 2\n\nSample: We conclude that high doses of 4-AP in the studied population produced several functional benefits not observed using lower doses .\n\nLabels: 1\n\nSample: Preserving the saphenous vein trunk during inguinal lymphadenectomy for vulval malignancies reduces multiple postoperative complications without compromising treatment outcome .\n\nLabels: 1\n\nSample: Peak-systolic strain ( S ) and strain rate ( SR ) were measured offline in 111 dysfunctional segments in the placebo and 88 in the treatment group at rest , low-dose ( LDD ) and peak-dose dobutamine ( PDD ) .\n\nLabels: 2\n\nSample: A recent open study suggested a high eradication rate combining omeprazole with the newer macrolide , clarithromycin .\n\nLabels: 0\n\nSample: Participants using the hydrogel dressings discontinued treatment sooner than participants in the lanolin ointment group .\n\nLabels: 4\n\nSample: The personal physicians of 336 patients who had participated in the CAFA study .\n\nLabels: 2\n\nSample: After T7 , MS underwent an increase in roughness ( = 0.09 0.80 ) ; ES underwent a decrease ( = -0.08 0.16 ) .\n\nLabels: 4\n\nSample: These results support the screening methods used and the interscreening interval of 4 years .\n\nLabels: 1\n\nSample: To investigate estimated outcome effects of a sports injury prevention intervention when analysed by means of a per protocol ( PP ) analysis approach .\n\nLabels: 3\n\nSample: In this 26-week , multi-center , double-blind , placebo-controlled , parallel-group study , men and women 40 years with moderate-to-severe COPD were randomized to glycopyrronium 50 g od or placebo ( 2:1 ) .\n\nLabels: 2\n\nSample: At baseline , 12 , and 60 + / - 3 months after surgery clinical parameters and standardized radiographs were obtained .\n\nLabels: 2\n\nSample: This study was conducted to determine if oral triiodothyronine supplementation could prevent the decrease of serum triiodothyronine levels that commonly occurs after cardiopulmonary bypass for pediatric congenital heart surgery .\n\nLabels: 3\n\nSample: Preoperative T , but not postoperative T , significantly improved DFS in patients who had a clinical partial response after AC ( hazard ratio [ HR ] = 0.71 ; 95 % CI , 0.55 to 0.91 ; P = .007 ) .\n\nLabels: 4\n\nSample: Patients were stratified according to 2 sets of additional risk factors similar to those used in recent trials ( MATCH , SPORTIF and PRoFESS ) ; risk of stroke , myocardial infarction , or vascular death was calculated in relation to the number of risk factors .\n\nLabels: 2\n\nSample: Differences in postvoid residue , IPSS and prostate volume between the two treatments could not be evaluated due to the small number of patients in each group .\n\nLabels: 4\n\nSample: A total of 90 eligible women aged 45-60 years were randomly assigned to three treatment groups ( 30 subjects/group ) with daily dosages of 0 ( placebo ) , 84 and 126 mg isoflavones for 6 months .\n\nLabels: 2\n\nSample: The solutions consisted of 1 % lidocaine with epinephrine concentrations of 0 , 1:50,000 , 1:200,000 , 1:800,000 , and 1:3,200,000 , and 0.25 % bupivacaine with the same epinephrine concentrations .\n\nLabels: 2\n\nSample: IV iron was discontinued and replaced with oral heme iron .\n\nLabels: 2\n\nSample: Each participant completed a questionnaire with items structured in a Likert five-point format with `` strongly agree '' and `` strongly disagree '' as the anchors .\n\nLabels: 2\n\nSample: The primary outcome was a composite of death from cardiovascular causes , hospitalization for heart failure , and stroke , systemic embolism , bleeding , and life-threatening arrhythmic events .\n\nLabels: 2\n\nSample: Surface EMG signals were recorded from rectus abdominis , external oblique , internal oblique , latissimus dorsi , iliocostalis lumborum , and multifidus bilaterally .\n\nLabels: 2\n\nSample: Radiographic healing is a common outcome measure in orthopedic trials and adjudication by outcome assessors is often conducted on the basis of plain films alone .\n\nLabels: 0\n\nSample: Volunteers underwent two treatment cycles separated by one resting cycle , with randomization to dose sequence .\n\nLabels: 2\n<Assistant>Got it. I will remember them.", "[Dialogue between User and Assistant on 2024-01-10 00:00]\n<User>I'm providing classification data with labels for your reference:\n\nSample: Finally , these scaling exponents were applied to and tested on group A and B posttraining data .\n\nLabels: 2\n\nSample: The mean induction-to-delivery time was shorter with the combination of the Foley bulb and vaginal misoprostol when compared with vaginal misoprostol alone ( 15.36.5 compared with 18.38.7 hours , difference -3.1 hours , 95 % confidence interval [ CI ] -5.9 to -0.30 ) .\n\nLabels: 4\n\nSample: It is not known whether or not delivering acupuncture triggers mechanisms cited as placebo and if acupuncture or sham reduces radiotherapy-induced emesis more than standard care .\n\nLabels: 0\n\nSample: Divalproex oral loading may produce rapid onset of antimanic and antipsychotic response comparable to that of haloperidol and with minimal side effects in the initial treatment of acute psychotic mania in a subset of bipolar patients .\n\nLabels: 1\n\nSample: Dental casts were obtained from the participants , who were randomized into 3 phase-1 early treatment groups : bionator , headgear/bite plane , or observation .\n\nLabels: 2\n\nSample: For 500 consecutive women , a slide obtained during colposcopy was immunostained for p16 ( INK4a ) / Ki-67 and independently interpreted by 7 readers without previous experience with dual staining .\n\nLabels: 2\n\nSample: Histological analysis of donor grafts indicated the presence of steatosis ( 50 % ) in one graft from the LT + IP group .\n\nLabels: 4\n\nSample: Patients with severe symptoms had a higher SPT response to Ara h 2 and Ara h 6 at low concentrations ( 0.1 micro g/mL ) and to Ara h 1 and Ara h 3 at higher concentrations ( 100 micro g/mL ) , compared with patients with mild symptoms .\n\nLabels: 4\n\nSample: To characterize relationships between specific immune cell subsets in bone marrow ( BM ) or granulocyte colony-stimulating factor-mobilized peripheral blood ( PB ) stem cells collected from unrelated donors and clinical outcomes of patients undergoing transplantation in BMTCTN 0201 .\n\nLabels: 3\n\nSample: After 15 months of hormone treatment mean plasma homocysteine concentration was lowered by 12.6 % compared with baseline ( P < .001 ; analysis of variance for repeated measures ) .\n\nLabels: 4\n\nSample: Serial blood samples were obtained and plasma concentrations were quantitated by HPLC .\n\nLabels: 2\n\nSample: The RP approach was successful in generating a parsimonious decision tree that predicted drug treatment retention from the 195 input variables .\n\nLabels: 4\n\nSample: Anaerobes most commonly isolated were Bacteroides fragilis group ( IAI ) and peptostreptococci ( SSSI and PI ) .\n\nLabels: 4\n\nSample: Subjects were randomly assigned to a group which received educational materials containing an interactive brochure designed using the Motivation Generating model ( Calcium CalculatorS ) , or to a group which received a calcium information brochure ( An Appetite for Good Health ) .\n\nLabels: 2\n\nSample: Pain assessment was done with VAS which showed mean of 19.2 and 15.5 mm ( p = 0.001 ) which was significant for butorphanol and tramadol respectively after 12 hours .\n\nLabels: 4\n\nSample: Mean volume of gas delivered during laparoscopic GBP was 650 + / - 220 liters .\n\nLabels: 4\n\nSample: The uPA activity and levels of uPA , suPAR , and PAI-1 were significantly decreased after SH injections in TMJs of OA patients ( P < .05 ) , and there was no difference after saline injection .\n\nLabels: 4\n\nSample: Fentanyl consumption in 24 h was recorded as a primary outcome .\n\nLabels: 2\n\nSample: The case for nurse-led clinics remains strong , but further research is required on ways to optimize current health status .\n\nLabels: 1\n\nSample: The rates of intracerebral and intracranial hemorrhage did not differ significantly between the two treatment groups ( 0.27 events per 100 patient-years with warfarin and 0.22 with aspirin , P = 0.82 ) .\n\nLabels: 4\n\nSample: Self-management is an approach used in chronic disease care to improve self-efficacy and wellness behaviors to facilitate participants to make informed choices and carry them out .\n\nLabels: 0\n\nSample: These data suggest that among patients receiving placebo abrupt improvements are a form of placebo response and gradual responses may be the result of spontaneous remission .\n\nLabels: 1\n\nSample: There was no difference in the renal or total Sequential Organ Failure Assessment score of the two groups ; 113/603 ( 18.7 % ) of patients assigned albumin were treated with renal replacement therapy compared to 112/615 ( 18.2 % ) assigned saline ( p = 0.98 ) .\n\nLabels: 4\n\nSample: Type 0 ( patent tubes ) , Type I ( distal tubal blockage ) , Type II ( intramural obstruction ) and Type III ( cornual obstruction ) .\n\nLabels: 4\n\nSample: There were 58.5 % ETT tips positioned too closely ( < 3 cm above the carina ) to the carina with the control method and 24 % with the study method ( P = 0.0001 ) .\n\nLabels: 4\n\nSample: Six out of these 9 occurred in the 24 patients with additional monitoring and were immediately detected by pulse oximetry or capnometry .\n\nLabels: 4\n\nSample: Although group 1 had a lower proportion of seroprotection at baseline , group and challenge dosage were not associated with postchallenge proportion of seroprotection .\n\nLabels: 4\n\nSample: Patients with Grades III and IV hemorrhoids were randomized to two groups : Ligasure hemorrhoidectomy and conventional diathermy .\n\nLabels: 2\n\nSample: Some patients in the active treatment group reported less pruritus-induced sleeplessness , but there was no statistically significant difference between the two treatment groups .\n\nLabels: 4\n\nSample: Three hearts in the adenosine group were probably not adequately drained and received additional hyperkalemic cardioplegia to maintain satisfactory cardioplegic arrest .\n\nLabels: 4\n\nSample: We explored whether telephone outreach , delivered by Medicaid managed care organization ( MMCO ) staff , could increase colorectal cancer ( CRC ) screening among publicly insured urban women , potentially reducing disparities .\n\nLabels: 3\n\nSample: Findings suggest that CT CAC assessment is a powerful adjunct in chest pain evaluation for the population at low-to-intermediate risk .\n\nLabels: 1\n\nSample: The breast reoperation rate was significantly lower in the MRI group : 11 of 220 ( 5 % ) versus 33 of 220 ( 15 % ) in the control group ( p < 0.001 ) .\n\nLabels: 4\n\nSample: 7.5 % of certoparin and 12.8 % of UFH treated patients experienced serious adverse events .\n\nLabels: 4\n\nSample: ClinicalTrials.gov NCT01188512 .\n\nLabels: 0\n\nSample: No differences were found in pain/physical discomfort , shortness of breath , or psychological well-being .\n\nLabels: 4\n\nSample: Before and following infusion of lecithinized superoxide dismutase for 28 days , the primary endpoint of forced vital capacity and the secondary endpoints of lactate dehydrogenase , surfactant protein-A , surfactant protein-D and Krebs von den Lungen-6 levels were measured in the serum .\n\nLabels: 2\n\nSample: Methodologically , LCSM appears well suited to analyzing longitudinal data from clinical trials in aged populations , by accounting for the high between-subject variability and providing information on the differential indication of the probed intervention .\n\nLabels: 1\n\nSample: CFR was measured using an intracoronary Doppler wire in 102 patients with AMI at baseline and at 8 months .\n\nLabels: 2\n\nSample: Regular treatment with terbutaline resulted in significant loss of bronchoprotection to AMP ( mean difference ( 95 % CI ) -1.7 ( -3.0 to 0.4 ) doubling dilutions ) but not to methacholine ( mean difference -0.1 ( -1.0 to 0.8 ) doubling dilutions ) .\n\nLabels: 4\n<Assistant>Thanks for the update. I've recorded these facts."]
[{"question": "Sentence: One hundred and fifty-nine patients received 1 g of metformin , twice daily continuously , and 415 repeated plasma metformin measurements were obtained after 3 , 6 , and 9 months of treatment .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: The preoperative body mass index was 44.5 kg/m ( 2 ) and 50.7 kg/m ( 2 ) for the weight loss group and nonweight loss group , respectively ( P = 0.0027 ) .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: Vaccine efficacy against all malaria episodes , vaccine efficacy against severe malaria , safety , and immunogenicity were also assessed .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: For validation , measurements were recorded using the Turesky et al. ( 1970 ) ( modification of the Quigley & Hein ( 1962 ) plaque index and the Addy et al. ( 1983 ) plaque area index .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: Butterbur root extract and music therapy might be superior to placebo and may represent promising treatment approaches in the prophylaxis of paediatric migraine .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "1"}, {"question": "Sentence: A total of 2,052 households were recruited into the study , comprising 7,341 individuals The odds ratios of testing positive by RDT with P. falciparum or P. vivax were > 75 % lower for all intervention arms compared with the control arm .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: Intervention participants had statistically significant decreases in weight ( kg ) ( -4.4 95 % CI = -5.6 , -3.2 ) and in systolic blood pressure ( -6.2 mm Hg , 95 % CI = -10.6 , -1.7 ) compared to controls .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: Data are reported as the mean + / - standard deviation .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: Both treatments show good results in the medium-term ; no differences were found between both groups regarding pain and residual disability .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "1"}, {"question": "Sentence: A greater percentage of patients achieved ASAS partial remission in the IFX+NPX group ( 61.9 % ; 65/105 ) than in the PBO+NPX group ( 35.3 % ; 18/51 ) at week 28 ( p = 0.002 ) and at all other visits ( p < 0.05 , all comparisons ) .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: The aim of this study is to evaluate the efficacy and the safety of a medical device containing a combination of Simethicone and Bacillus coagulans in the treatment of IBS .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "0"}, {"question": "Sentence: However , baseline HA and platelet counts were best at predicting histological progression ( area under the curve ( AUC ) = 0.663 ) .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: Data for efficacy were available for 126 patients ; safety data were available for 128 patients .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: Anaesthetic duration , postoperative pain and emesis as well as discharge time did not differ between groups .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: CD8 + T cells from SLN and peripheral blood were tested for reactivity in an IFNgamma ELISPOT assay against the full-length MART-1 antigen and a number of HLA-A1 , HLA-A2 , and HLA-A3-restricted epitopes derived from a range of melanoma-associated antigens .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: Intraoperative intravenous and postoperative oral clindamycin , or placebo for 7 days , were administered .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: Protection through RIPC in patients undergoing CABG surgery does not appear to be associated with enhanced autophagy in LV myocardium at early reperfusion .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "1"}, {"question": "Sentence: The mean ( SD ) ages of the subjects were 24.0 ( 2.6 ) and 24.0 ( 1.9 ) years in the 250 - and 500-mg groups , respectively .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: The noncompliance rate among those with less than a grade 10 education was 50 % , grade 10-13 education 34 % , some college education 15 % and some university education 9 % .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: The erythromycin group had a slightly shorter length of time to passage of flatus ( 4.1 + / - 1.3 vs. 4.4 + / - 1.1 days ; P = 0.03 ) .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: Markers of biological activity , including neutrophil and total white cell counts , C reactive protein , and IL-6 concentrations , were lower in rhIL-1ra treated patients .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: Forty-eight patients were randomly allocated to three groups in which three different tensions , 8 , 12 , or 15 kg force , was applied on the reconstructed ACL during the operation .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: From May 1991 to May 1993 , 207 patients were enrolled onto this study and randomized to receive intravenous ( IV ) EPI ( 60 mg/m2 on days 1 and 2 ) alone or with LND ( 600 mg orally daily ) .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: A total of 179 patients aged 40 and over with a diagnosis of CHF levels II to IV were recruited from Winnipeg and Central Manitoba and randomized into three treatment groups : one receiving standard care , a second receiving Health Lines ( HL ) intervention and a third receiving Health Lines intervention plus in-house monitoring ( HLM ) .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: The proportion of hand cultures positive for S. aureus in the mupirocin group after therapy was lower than in the placebo group ( 2.9 % compared with 57.6 % ) .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: Treatment-related mild-to-moderate visual disturbances were experienced by six out of 12 subjects .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: Six - to 17-month-old underweight infants ( weight for age < -2 ) , whose weight was greater than 5.5 kg and weight-for-height z score greater than -3 received for 12 weeks at home 1 of 8 food supplementation schemes : nothing , 5 , 25 , 50 , or 75 g/day milk-based FS or 25 , 50 , or 75 g/day soy-based FS .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: There were 10 exclusions after random assignment because of inappropriate inclusion .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: All patients were masked for the trial objectives .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: The fever duration was 46.8 h ( 45.0 % ) less in the oseltamivir group than that in the control group .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: Ninety-six percent of inter-hospital transfers for angioplasty were completed within 2 h. No patients were lost to follow-up .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: At the end of the experimental period , plaque was assessed , and the panelists filled out a questionnaire .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: The lower limits of the confidence intervals did not include -10 % , the minimum relative attributable effect believed to be clinically important .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: The progression-free survival benefit associated with MPR-R was noted in patients 65 to 75 years of age but not in those older than 75 years of age ( P = 0.001 for treatment-by-age interaction ) .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: Clozapine facilitates participation in psychosocial treatment , and such enhanced participation is associated with improved quality-of-life and symptom outcomes .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "1"}, {"question": "Sentence: Recruitment rates at the community health center , elder program , and community registry were 48 % , 69 % , and 8 % , respectively .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: The total dose ( micrograms per kilogram per day , mean + / - SD ) of fentanyl at postoperative days 1 ( 8.3 + / -3.7 vs. 18.1 + / -4.6 , P = 0.021 ) and 2 ( 7.0 + / -2.4 vs. 16.6 , P = 0.042 ) was significantly less in the fentanyl-acetaminophen group compared with that in the fentanyl group .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: Respiratory effort , respiratory rate and oxygen saturation were also measured repeatedly .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: Pain intensity with a pain visual analogic scale ( VAS ) and verbal rating scale ( VRS ) and pain disability with McGill Pain Questionnaire Short Form ( SFMPQ ) , Roland Morris Disability Questionnaire ( RMQ ) and Oswestry Low Back Pain Disability Questionaire ( ODQ ) .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: ClinicalTrials.gov Identifier : NCT00519311 .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "0"}, {"question": "Sentence: The corresponding values for 1-OH MDZ were 789.6 ( 697.6 , 893.6 ) and 791.4 ( 701.7 , 892.6 ) microg l ( -1 ) h.\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: Final results and analysis of prognostic factors are reported .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "0"}, {"question": "Sentence: The IPSS did not differ between the two groups at 3 , 6 , and 12 mo postoperatively .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: However , at 24 hours , basal P-selectin expression declined in patients ( P = 0.0025 versus baseline ) , whereas ADP-stimulated P-selectin expression was lower in patients than in control subjects ( 48 % versus 69 % , P = 0.0004 ) .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: Hospitalization burden was significantly reduced across all levels of care ( P < 0.05 ) .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: No baby had adverse reactions .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: It also tested whether triple anti-platelet therapy is superior to dual anti-platelet therapy in inhibiting platelet reactivity in patients receiving percutaneous coronary intervention with drug-eluting stent .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: Atelectasis also causes post-perfusion lung injury .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "0"}, {"question": "Sentence: The ketoprofen patch was not inferior to diclofenac gel in reducing the baseline pain during daily activities ( difference of -1.17 mm in favour of ketoprofen patch , 95 % CI ( -5.86 to 3.52 ) , reducing to the baseline VAS 79 % .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: The treatment group was divided into four groups .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: No differences were observed between groups at baseline .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: Enteral feedings on day 1 predicted a pH 4 ( P = 0.01 ) .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: Triple combination with valsartan gave a greater increase of E/A ratio ( p < 0.05 between groups ) .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: Visual analog scale ( VAS ) values immediately after and 5 min after removal of nasal packing , effects of the procedure on patient comfort and its side-effects were evaluated separately .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: We examined whether an analogous effect could be demonstrated in 10 weeks of residential treatment of 80 social phobia subjects .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "0"}, {"question": "Sentence: Bacterial isolates were susceptible to most of the antibiotics recommended for antibiotic prophylaxis , but erythromycin , gentamycin , penicillin G , and teicoplanin were only 80 % ( or less ) effective in their efficacy while chlorhexidine , amoxicillin , clindamycin , and vancomycin were between 92 and 100 % effective .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: Human corticotropin-releasing factor has strong antiedematous properties as a result of direct action on blood vessels independent of endocrine function and has been shown to have a positive effect on vascular permeability in animal studies independent of corticosteroid effects .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "0"}, {"question": "Sentence: To design and describe an effective rehabilitation programme for use in an ongoing trial on the efficacy of multidisciplinary brain injury rehabilitation for moderately head injury military service members .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "3"}, {"question": "Sentence: The TRQI group was administered with the intravenous injections of 20 mL TRQI once a day and conventional Western medicine treatment .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: A second analysis , of planning time off work , therefore , examined the 620 respondents in the intervention condition more closely and found that those who planned were significantly more likely to attend than those who did not .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: In comparable patients , there is no late survival difference in the first postoperative decade between the Ross procedure and mechanical aortic valve implantation with optimal anticoagulation self-management .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "1"}, {"question": "Sentence: Randomised clinical trial with control .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: Manipulative therapy and exercise can reduce the symptoms of cervicogenic headache , and the effects are maintained .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "1"}, {"question": "Sentence: The aim of this study was to compare the efficacy and tolerability of morning-only ( AM-only ) polyethylene glycol electrolyte solution ( PEG-ELS ) to split-dose ( PM/AM ) PEG-ELS for afternoon colonoscopy .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "3"}, {"question": "Sentence: Age , averaged room humidity , rectal temperature decrease , oesophageal temperature decrease and oesophageal-skin difference data were compared using a Kruskal-Wallis test .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: The equipment could be fitted with the scope that allows three-dimensional observation of instrument localization in the bowel .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: Unique identifier : CT-981-423-239 .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "1"}, {"question": "Sentence: We studied 19 healthy volunteers and seven patients with non-cardiac chest pain .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: Drivers , 178 , age > or = 70 years with physical , but without substantial visual ( acuity 20/40 or better ) or cognitive ( Mini Mental State Examination score > or = 24 ) impairments were recruited from clinics and community sources .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: This resulted in a sample of 78 adults , randomized according to date of admission .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: Success in changing multiple behaviors was not associated with intervention mode ; both simultaneous and sequential interventions can be applied .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "1"}, {"question": "Sentence: The pressure is higher in a lateral than in a supine position .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "0"}, {"question": "Sentence: Participants and outcome-assessors were masked to the treatment group .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: Primary outcome , measured at 4 weeks and 18 weeks post randomisation , was the proportion of women improved on the Edinburgh Postnatal Depression Scale ( EPDS ) , that is scoring < 13 .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: Patients also were classified by whether the margin of resection was microscopically normal ( category 1 ) , contained nonspecific changes ( category 2 ) , were suggestive but not diagnostic for CD ( category 3 ) , or were diagnostic for CD ( category 4 ) .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: In an acute trial ( Study 1 ) , 19 subjects received either 80 mg AS as a single dose or placebo .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: Depression is a disabling , prevalent condition .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "0"}, {"question": "Sentence: Randomized , prospective trial .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: Daily crosswords may be a simple and effective means of bolstering PVF performance in older people .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "1"}, {"question": "Sentence: The patients ' high mortality was not influenced by the mode of anticoagulation .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: Lung impedance was measured during suction , and end-expiratory lung impedance was measured at baseline and postsuctioning using electrical impedance tomography .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: In adipose tissue , rosiglitazone increases LPL mRNA abundance and LPL transport rate and possibly increases endothelial binding sites for LPL , but affects neither tissue LPL activity nor LPL rate of action .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "1"}, {"question": "Sentence: At 2 and 18 hours after end of study infusions SVI was more increased in HES [ 143 % ( 38 ) and 148 % ( 41 ) of pre-infusion values ] and HA [ 143 % ( 35 ) and 163 % ( 42 ) of pre-infusion values ] groups than in GEL [ 116 % ( 23 ) and 125 % ( 30 ) ] group ( P = 0.047 at 2 hours and P = 0.033 at 18 hours ) .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "1"}, {"question": "Sentence: For these subgroups the pain reduction in response to training ranged from 1.1 to 1.8 .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: To evaluate whether drug treatment for mild-to-moderate hypertension in middle-aged patients improves survival and to study how the conflicting results of individual trials may be explained .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "3"}, {"question": "Sentence: min-1 ) or the placebo group .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: Intestinal permeability was measured preoperatively ( PO ) , and at day 1 ( D1 ) and day 3 ( D3 ) after surgery using the lactulose/mannitol absorption test .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: The final comparative series included 32 cases of plate fixation and 28 cases of intramedullary nail fixation .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: Bioavailability with paired analysis of neonates ( n = 5 ) receiving 100 % parenteral carnitine at week 1 and 100 % enteral carnitine at week 8 was 83.7 % + / - 41.2 % ( 30.1 % -140.6 % ) .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: Exclusion criteria included complicated diverticulitis , suspected cancer , and previous extensive abdominal surgery .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: The 62 Cp-positive patients given roxithromycin showed a significantly decreased IMT progression after 2 years compared with the Cp-positive patients without therapy ( 0.07 [ 0.045 to 0.095 ] versus 0.11 [ 0.088 to 0.132 ] mm/year ; P < 0.01 ) .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: Percutaneous nephrolithotomy ( PCNL ) is a common endourologic procedure with less morbidity than open surgery .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "0"}, {"question": "Sentence: The base-case results were robust .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: Compared with usual care , in this group 5100 had to be paid for each additional abstinent participant .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: Coadministration of EZE and statins provides inhibition of 2 sources of cholesterol , leading to greater reductions in low-density lipoprotein cholesterol ( LDL-C ) than with either agent alone .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "0"}, {"question": "Sentence: In a multiple logistic regression analysis breast feeding appeared to protect against wheeze , nasal discharge , colds , vomiting and diarrhoea .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "4"}, {"question": "Sentence: Need for more than one electrode ; reason for replacement ; trace quality ; scalp trauma ; direct financial costs .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: Preablation patients underwent two 30 min observation periods in a randomized , blinded fashion during which they were either in baseline AF ( pacer set to default V/VI 50/min ) or being paced using a rhythm stabilizing algorithm ( RSA ) designed to regularize rhythm without changing baseline ventricular rate .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: Primary outcome was return to work .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "2"}, {"question": "Sentence: A further study with more participants seems warranted .\n\nWhat are the labels for the above medical abstract sentence?", "answer": "1"}]